• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Sodium Chloride 23.4% Injection

 Status: Currently in Shortage

 » Date first reported: No date available
 » Therapeutic Categories: Gastroenterology; Endocrinology/Metabolism; Total Parenteral Nutrition; Pediatric

American Regent/Luitpold (Reverified 10/21/2014)

Company Contact Information:
800-645-1706

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
30 mL vials, pkg of 25 (NDC 00517-2930-25) Unavailable- no product available for release. No plan to manufacture. Shortage per Manufacturer: American Regent/Luitpold has discontinued manufacturing Concentrated Sodium Chloride Injection 23.4%. Discontinuation of the manufacture of the drug
100 mL vials, pkg of 25 (NDC 00517-2900-25) Unavailable- no product available for release. No plan to manufacture. Shortage per Manufacturer: American Regent/Luitpold has discontinued manufacturing Concentrated Sodium Chloride Injection 23.4%. Discontinuation of the manufacture of the drug

Fresenius Kabi USA, LLC (Reverified 10/07/2014)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
30 mL vials (NDC 63323-0087-30) Available. Check wholesaler for inventory. Demand increase for the drug
100 mL vials (NDC 63323-0088-61) Currently backordered. Next release anticipated October 2014. Check wholesaler for inventory. Demand increase for the drug
200 mL vials (NDC 63323-0088-63) Currently backordered. Next release anticipated October 2014. Check wholesaler for inventory. Demand increase for the drug

Hospira, Inc. (Reverified 10/23/2014)

Company Contact Information:
877-946-7747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
4 mEq/mL; 100 mL bottle (NDC 0409-1141-02) Next delivery and expected recovery TBD. Shortage per Manufacturer: Manufacturing delay Other
4 mEq/mL; 250 mL bottle (NDC 0409-1130-02) Next delivery and expected recovery TBD. Shortage per Manufacturer: Manufacturing delay. Other
-
-